Ed Ledent

Ed (Edouard) Ledent is currently a Director in R&D Strategy & Portfolio at GSK, where they lead quantitative analyses that inform portfolio management decisions. They have extensive experience in statistical modeling and decision sciences, having previously held positions at GlaxoSmithKline and Eli Lilly, where they contributed to vaccine development and early-phase clinical studies. Ed began their career as a Research Scientist at Université Libre de Bruxelles and has been recognized for their creativity, leadership, and problem-solving skills in dynamic, international team environments. Their work is characterized by a strong emphasis on innovation and the reliable assessment of complex decision-making scenarios.